水友性药物输送的进步:生物素在酸微粒中的封装
Iria Naveira-Souto1,2, Elisabet Rosell-Vives2, Eloy Pena-Rodríguez2
1Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain.
Pharmaceutics
|September 27, 2025
概括
这项研究使用酸盐和Eudragit® E100开发了含有生物素的微粒. 这些微粒显示出高封装效率和受控释放,为改善水友性药物递送提供了潜力.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
背景情况:
- 水友性药物在微粒中的封装增强了稳定性和生物可用性.
- 生物素的治疗用途受到降解和薄膜透性的限制.
研究的目的:
- 使用酸盐,Eudragit® E100和CaCl2.2开发和描述含有生物的微粒.
- 评估这些新型微粒子配方的潜在应用.
主要方法:
- 微粒通过外部离子凝与探头超声波制备.
- 尤德拉吉特®E100被纳入作为复合剂.
- 对配方变量进行了选,以优化微粒子特性.
主要成果:
- 生物素微粒的尺寸为634nm,PDI为0.26,而zeta电位为-45mV.
- 封装效率达到了90.5%.
- 试验室释放研究显示,根据韦布尔动力模型,受控释放特征.
结论:
- 聚合物封装有效地克服了水友性药物递送的局限性.
- 开发的生物素微粒对局部和口服配方有希望.
- 这突显了微封装对不稳定生物活性化合物的多功能性.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
186
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
186
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
200
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
200
Bioavailability Enhancement: Drug Solubility Enhancement
221
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
221
Factors Influencing Drug Absorption: Physicochemical Parameters
820
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
820
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
183
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
183
Drug Biotransformation: Overview
3.7K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.7K


